Pasco, Florencio .
HRN: 24-46-10 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/23/2024
MUPIROCIN 2%, 15G (TUBE)
01/23/2024
01/30/2024
APPLY TO AFFECTED AREA
0
BID
Bed Sore
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes